ALC Nov 2024 100.000 call
| Previous close | 2.7000 |
| Open | 2.7000 |
| Bid | 1.7000 |
| Ask | 3.2000 |
| Strike | 100.00 |
| Expiry date | 2024-11-15 |
| Day's range | 2.7000 - 2.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | 46 |
ZacksWhy Alcon (ALC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Globe NewswireOculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board
Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of DirectorsBaruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of the Scientific Advisory BoardOculis established a CHF 50 million flexible loan facility with funds and accounts managed by BlackRock ZUG, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: O
ZacksIs Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.
